New Therapy Helps Patients With Tough-to-Treat Bladder Cancers
FRIDAY, Dec. 6, 2024 (HealthDay News) — There’s new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report. An experimental new drug with the unwieldy name of cretostimogene grenadenorepvec spurred complete remission of the cancer in three-quarters of patients who hadn’t responded toContinue Reading